Efficacy News and Research

RSS
Conservative therapies recommended over routine use of OTC cough/cold products in children

Conservative therapies recommended over routine use of OTC cough/cold products in children

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Sistemic announces availability new SistemRNA Technology

Sistemic announces availability new SistemRNA Technology

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

Probiotic supplementation helps ELBW infants gain weight: Study

Probiotic supplementation helps ELBW infants gain weight: Study

Preclinical safety data reports Natural S-equol has little effect on 2 reproductive hormones

Preclinical safety data reports Natural S-equol has little effect on 2 reproductive hormones

SGB procedure holds potential promise for PTSD treatment

SGB procedure holds potential promise for PTSD treatment

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

Seasonal flu vaccine ups the risk of getting H1N1 flu

Seasonal flu vaccine ups the risk of getting H1N1 flu

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

NovaBay to present data on Aganocide compounds at ARVO annual meeting

NovaBay to present data on Aganocide compounds at ARVO annual meeting

Celtic Pharma commences enrolment in Phase III trial of TDT 067 for onychomycosis

Celtic Pharma commences enrolment in Phase III trial of TDT 067 for onychomycosis

MannKind reports first-quarter net loss of $44.7 million applicable to common stockholders

MannKind reports first-quarter net loss of $44.7 million applicable to common stockholders

Boston Scientific to present multiple clinical abstracts on its endoscopy products at DDW 2010

Boston Scientific to present multiple clinical abstracts on its endoscopy products at DDW 2010

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Practicing NPIs may help limit transmission of pandemic flu: Study

Practicing NPIs may help limit transmission of pandemic flu: Study

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Public health officials lay out opportunities, challenges related patient care at USP 2010 Membership Meeting

Public health officials lay out opportunities, challenges related patient care at USP 2010 Membership Meeting

Gonorrhea may soon become untreatable according to WHO

Gonorrhea may soon become untreatable according to WHO

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.